Literature DB >> 24043612

Pediatric patients with Marfan syndrome: frequency of dural ectasia and its correlation with common cardiovascular manifestations.

S Veldhoen1, V Stark2, G C Mueller2, T Derlin1, T A Bley3, J Weil2, Y von Kodolitsch4, T S Mir2.   

Abstract

PURPOSE: Marfan syndrome (MFS) is a genetic disorder of the connective tissue. Aortic root dilation is a main criterion of the Ghent Nosology. Dural ectasia and the presence of mitral valve prolapse (MVP) contribute to its systemic score. The purpose of this study was to investigate the frequency of dural ectasia and its correlation with cardiovascular manifestations in a pediatric study population. PATIENTS AND METHODS: 119 pediatric patients with confirmed or suspected MFS were examined in the local Marfan Clinic. 31 children with MFS who underwent magnetic resonance imaging (MRI) were included. Each patient was evaluated according to the Ghent nosology. Echocardiography was used to measure the aortic root diameter and assess the presence of MVP and mitral regurgitation. Z-scores were calculated for the evaluation of the aortic root diameters. MRI was performed to determine the dural sac ratio (DSR).
RESULTS: The prevalence of dural ectasia was 90.3 %, of aortic root dilation 32.2 %, of MVP 64.5 % and of mitral regurgitation 51.6 %. DSR at L5 correlated with the intraindividual z-scores (slope, 3.62 ± 1.5 [0.56; 6.68]; r = 0.17; p = 0.02; F = 5.84). Z-scores ≥ 2 were accompanied by dural ectasia in 100 %, MVP in 95 % and mitral regurgitation in 100 % of cases. MVP was accompanied by mitral regurgitation in 70 % of cases.
CONCLUSION: As the examined cardiac manifestations show a coincidence with dural ectasia in 95 - 100 % of cases, MRI for diagnostic dural sac imaging should be reserved for MFS suspicions with the absence of those manifestations in order to establish the diagnosis according to the Ghent criteria. Thus, the present study supports the recent downgrading of dural ectasia to a contributor to the systemic score. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2013        PMID: 24043612     DOI: 10.1055/s-0033-1350421

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  6 in total

Review 1.  [Latest advances in the diagnosis and treatment of Marfan syndrome].

Authors:  Shu-Ting Yang; Fang Luo
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-07-15

2.  Marsupialization and distal obliteration of a lumbosacral dural ectasia in a nonsyndromic, adult patient.

Authors:  Ha Son Nguyen; Andrew Lozen; Ninh Doan; Michael Gelsomin; Saman Shabani; Dennis Maiman
Journal:  J Craniovertebr Junction Spine       Date:  2015 Oct-Dec

Review 3.  The Musculoskeletal Manifestations of Marfan Syndrome: Diagnosis, Impact, and Management.

Authors:  Lily Pollock; Ashley Ridout; James Teh; Colin Nnadi; Dionisios Stavroulias; Alex Pitcher; Edward Blair; Paul Wordsworth; Tonia L Vincent
Journal:  Curr Rheumatol Rep       Date:  2021-11-26       Impact factor: 4.592

4.  Aortic root ectasia as a phenotypic feature of a mitochondrial disorder.

Authors:  Josef Finsterer
Journal:  Clin Case Rep       Date:  2018-06-17

Review 5.  A scoping review presenting a wide variety of research on paediatric and adolescent patients with Marfan syndrome.

Authors:  Ingeborg Beate Lidal; Trine Bathen; Heidi Johansen; Gry Velvin
Journal:  Acta Paediatr       Date:  2020-02-17       Impact factor: 2.299

6.  Mitral Valve Prolapse and Its Motley Crew-Syndromic Prevalence, Pathophysiology, and Progression of a Common Heart Condition.

Authors:  Jordan E Morningstar; Annah Nieman; Christina Wang; Tyler Beck; Andrew Harvey; Russell A Norris
Journal:  J Am Heart Assoc       Date:  2021-06-22       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.